Cerity Partners LLC Bicycle Therapeutics PLC Transaction History
Cerity Partners LLC
- $48.7 Billion
- Q1 2025
A detailed history of Cerity Partners LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Cerity Partners LLC holds 13,350 shares of BCYC stock, worth $120,951. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,350Holding current value
$120,951% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCYC
# of Institutions
104Shares Held
43.6MCall Options Held
12.1KPut Options Held
17.4K-
Baker Bros. Advisors LP New York, NY10.9MShares$98.6 Million1.69% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.55MShares$41.3 Million0.15% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$31.3 Million8.16% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$24.1 Million0.12% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$19.9 Million0.43% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $269M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...